Literature DB >> 1825485

An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

B E Henricson1, R Neta, S N Vogel.   

Abstract

In this report, administration of a recombinant interleukin-1 receptor antagonist protein to mice was found to inhibit induction of colony-stimulating factor as well as induction of early endotoxin tolerance by lipopolysaccharide. These findings provide direct evidence that interleukin-1 is an intermediate in these two lipopolysaccharide-induced phenomena.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1825485      PMCID： PMC258388          DOI： 10.1128/iai.59.3.1188-1191.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice.

Authors:  G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools.

Authors:  G S Madonna; S N Vogel
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

5.  Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody.

Authors:  S N Vogel; E A Havell
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

Authors:  W P Arend; H G Welgus; R C Thompson; S P Eisenberg
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Authors:  S P Eisenberg; R J Evans; W P Arend; E Verderber; M T Brewer; C H Hannum; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

8.  Granulocyte stem cells are decreased in humans with fatal burns.

Authors:  V M Peterson; W A Robinson; S F Wallner; C Rundus; J F Hansbrough
Journal:  J Trauma       Date:  1985-05

9.  Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.

Authors:  J R Zucali; C A Dinarello; D J Oblon; M A Gross; L Anderson; R S Weiner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307
View more
  14 in total

1.  Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling.

Authors:  Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

2.  What We Do When We Suppress Fever.

Authors:  Philip A Mackowiak
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

3.  Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia.

Authors:  S N Vogel; B E Henricson; R Neta
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 4.  Cordelia, Goneril and the febrile response.

Authors:  P A Mackowiak
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

5.  Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip.

Authors:  Khalid Al-Shaghdali; Barbara Durante; Christopher Hayward; Jane Beal; Andrew Foey
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

6.  Granulocyte-macrophage colony-stimulating factor modulates rapid eye movement (REM) sleep and non-REM sleep in rats.

Authors:  M Kimura; T Kodama; M C Aguila; S Q Zhang; S Inoue
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

7.  Differential regulation of cytokine production in lipopolysaccharide tolerance in mice.

Authors:  A Erroi; G Fantuzzi; M Mengozzi; M Sironi; S F Orencole; B D Clark; C A Dinarello; A Isetta; P Gnocchi; M Giovarelli
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma.

Authors:  D R Smith; S L Kunkel; T J Standiford; S W Chensue; M W Rolfe; M B Orringer; R I Whyte; M D Burdick; J M Danforth; A R Gilbert
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

9.  The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.

Authors:  J Mancilla; P García; C A Dinarello
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

10.  Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A.

Authors:  B E Henricson; C L Manthey; P Y Perera; T A Hamilton; S N Vogel
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.